Clinical Trial Update: STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines) [Phase 2]

View source ↗

Summary

Phase 2 STOP-CA trial tested whether statins can prevent cardiotoxicity from anthracycline chemotherapy in patients with heart failure; results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Statins

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2023-12-18